A cross-sectional study to estimate the antibody seroprevalence of the PPR virus and determine the associated risk factors was conducted from February 2021 to May 2022 in the Guangua and Jawi districts of the Awi zone. Of the total 380 sera samples tested using cELISA, 231 (60.8 %) were found positive for the PPRV antibody.
View Article and Find Full Text PDF